Gestational Hypertension

Gestational hypertension or pregnancy-induced hypertension (PIH) is the development of new hypertension in a pregnant woman after 20 weeks gestation without the presence of protein in the urine or other signs of Pre-eclampsia in pregnancy. It is a temporary diagnosis for hypertensive pregnant women who do not meet criteria for preeclampsia or chronic hypertension (hypertension first detected before the 20th week of pregnancy). The diagnosis is changed to, Preeclampsia, if proteinuria or new signs of end-organ dysfunction develop and chronic (primary or secondary) hypertension, if blood pressure elevation persists ≥12 weeks postpartum.

The risk factors for Gestational hypertension comprise maternal causes like obesity, past history or adolescent pregnancy, multiple gestations, and family history. There is no specific treatment, but it is monitored closely to rapidly identify pre-eclampsia and its life-threatening complications. Drug treatment options are limited, as many antihypertensive drugs may negatively affect the foetus. During gestational hypertension a women must be offered an integrated package of care, covering admission to hospital, treatment, measurement of blood pressure, testing for proteinuria and blood tests.

  • Classification of pregnancy induced hypertension
  • Risk factors for gestational hypertension
  • Pre-eclampsia and eclampsia
  • Pathogenesis of pre-eclampsia
  • Management of hypertension in pregnancy
  • Drug treatment of gestational hypertension
  • Long term cardiovascular sequelae of gestational hypertension

Related Conference of Gestational Hypertension

October 22-23, 2018

Global Cardiology Summit

Osaka, Japan
Oct 22- Oct 24 , 2018

27th European Cardiology Conference

Rome, Italy
November 05-06, 2018

28th World Congress on Cardiology and Heart Diseases


Hyatt Place Airport Hotel - Amsterdam, Netherlands
November 15-17, 2018

World Heart Rhythm Conference

Istanbul, Turkey
November 19-20, 2018

29th World Cardiology Conference

Edinburgh, Scotland
November 21-22, 2018

International Conference on Cardiovascular Diseases and Therapeutics

| Paris, France

Venue: Holiday Inn Paris - Marne la Vallée

November 21 - 22, 2018

6th World Congress on Hypertension and Public Health

Holiday Inn Paris - Marne la Vallé, 2 Boulevard du Levant, Noisy-le-Grand 93167
February 18-19, 2019

30th European Heart Diseases and Heart Failure Congress

Amsterdam, Netherlands
Feb 28-March 01, 2019

World Cardiology Experts Meeting

Osaka, Japan
March 15-16, 2019

4th Global Summit on Heart Diseases

Singapore
March 18-20, 2019

Middle East Heart Congress

Dubai, UAE
March 27- 28, 2019

5th World Heart Congress

Sydney, Australia
April 15 -16, 2019

5th World Heart Congress

Amsterdam, Netherlands
April 17-18, 2019

World Congress on Cardiac Surgery & Medical Devices 2019

Montreal | Quebec | Canada
April 19-20, 2019

World Heart and Brain Congress

Chicago, USA
April 25-26, 2019

2nd World Heart and Brain Conference

Helsinki, Finland
April 29 - May 01, 2019

4th World Heart Congress

Kyoto, Japan
June 17-19, 2019

31st Annual Cardiologists Conference

Rome, Italy
July 01-02, 2019

European Cardiology Congress

Prague | Czech Republic
July 10-11, 2019

25th World Cardiology Conference

Osaka, Japan
July 10-11,2019

26th Annual Cardiologists Conference

Osaka,Japan
July 26-27, 2019

4th International Conference on Hypertension and Healthcare

Melbourne, Australia
July 31-August 01, 2019

27th International Congress on Cardiology and medical interventions

Chicago, Illinois, USA

World Cardiology and Cardiologist Meet

August 5 - 7, 2019 Canne, France
August 19- 20, 2019

7th World Heart Congress

Vienna, Austria

Gestational Hypertension Conference Speakers

Recommended Sessions

Related Journals

Are you interested in